Oncologic causes of oculopalatal tremors: neurophysiology and treatment

Abstract

Oculopalatal tremor (OPT) is an acquired pathology characterized by continuous and rhythmical soft palatal movements combined with pendular nystagmus. Aside from vascular lesions, oncological masses affecting the dentatorubro-olivary pathway can impair brainstem and/or cerebellar pathways, manifesting as dyssynchronous movement. In this review, we delve into the neurophysiology of OPT along with oncological causes and treatment options based on the most recent clinical trial data. This literature review includes medication treatment data from clinical trials enrolling individuals with features of OPT, including acquired pendular nystagmus (APN). Trials were deemed eligible for inclusion in this review if one or more participants had symptoms determined by the trial authors to be caused by OPT. Trials investigating the treatment of APN secondary to a separate cause, such as multiple sclerosis, were excluded from this review. Several early treatments failed to demonstrate a benefit for patients with APN due to OPT. Trials of anticholinergic agents were largely ineffective and poorly tolerated. Botulinum toxin A demonstrated improvement in APN symptoms. Most recently, trials including memantine and gabapentin have demonstrated success with attenuation of APN. Surgical modalities such as DBS have yet to show improvement, though with only a single case report as evidence. Oculopalatal tremor is a unique manifestation of posterior fossa tumors disrupting the Guillain-Mollaret triangle. Symptom control through medication management has had limited success attributed to poor response and medication intolerance. Surgical modalities like DBS may have an emerging role in OPT treatment by targeting dyssynchronous activity in the dentatorubro-olivary pathway.

Vestibular Rehabilitation of Patient with Hypertrophic Olivary Degeneration: A Case Report

“…However, even with synchronization, the output of the inferior olivary nucleus is too small to induce ocular oscillations. For the weak oscillations emanating from the inferior olivary nucleus to become clinically visible and symptomatic, they to be amplified by the cerebellar cortex 20 . OPM results from a dual mechanism: ignition of a generator, the inferior olivary pacemaker, followed by an amplification/modulation by the cerebellum.…”

The Impact of Triangle Hierarchical Management on Self-Management Behavior and Quality of Survival in Parkinson's Patients

“…It has a positive effect on improving patients' prognosis, preventing disease recurrence, improving quality of life and reducing the burden on patients and their families. The Triangle Chronic Disease Tiered Management Model was developed by Kaiser Permanente, a large managed care organization in California, and has been used since 2002 to manage the care of patients with chronic diseases (9,10). The model divides patients into high-risk, moderaterisk, and stable tiers, and then provides specialized medical care proportional to the needs of each tier, creating a pyramidal tiered management model that is more economical and The model is a pyramidal hierarchical management model that treats patients more economically and effectively (11).…”